IDX-listed laboratory chain Diagnos to buy DNA company Asa Ren for $24m
Diagnos plans to issue 921 million new shares at 505 rupiah apiece in the 465 billion rupiah rights issue.
Stay updated with breaking news from Orbit Fund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Diagnos plans to issue 921 million new shares at 505 rupiah apiece in the 465 billion rupiah rights issue.
JAKARTA, Indonesia, July 22, 2022 /PRNewswire/ --Agritech startup KedaiSayur announced its Series A funding, led by Kejora-SBI Orbit to accelerate growth and build a strong farm-to-table infrastructure. This round of financing is also followed by previous investors Triputra Group and a few other strategic investors. "We'd like to say thank you to all investors for supporting our journey in improving the effectiveness of Indonesia's agriculture supply chain. Through this Series A funding, we hope to accelerate the growth of KedaiSayur in building a strong supply chain infrastructur...
N continuation to our previous Tech Deals series (Tech Deals Vol. 1, Vol. 2 and Vol. 3), we provide herein, the recent tech deals completed between the period of 1 January and 31 March 2022...
/PRNewswire/ -- Nandu Kuppuswamy, CFA, the former Head of Investor Relations at Sandstone Capital, >$1B AUM hedge fund, has joined 3Lines as a partner and...
/PRNewswire/ -- Nandu Kuppuswamy, CFA, the former Head of Investor Relations at Sandstone Capital, >$1B AUM hedge fund, has joined 3Lines as a partner and...